Randomized, double-blind, placebo-controlled trial of arimoclomol in rapidly progressive SOD1 ALS

Overview of attention for article published in Neurology, January 2018

Altmetric Badge

About this Attention Score

So far, Altmetric has seen 8 X posts from 8 X users, with an upper bound of 121,096 followers.

Randomized, double-blind, placebo-controlled trial of arimoclomol in rapidly progressive SOD1 ALS. https://t.co/Sg0MUA9BmL

RT @GreenJournal: Randomized, double-blind, placebo-controlled trial of arimoclomol in rapidly progressive SOD1 ALS https://t.co/LOnzaz02X4…

RT @GreenJournal: Randomized, double-blind, placebo-controlled trial of arimoclomol in rapidly progressive SOD1 ALS https://t.co/LOnzaz02X4…

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 4 additional X posts.